II 

Calendar No. 675 

111TH CONGRESS 

2D SESSION S. 3036 

To establish the Office of the National Alzheimer’s Project. 

IN THE SENATE OF THE UNITED STATES 

FEBRUARY 24, 2010 

Mr. BAYH (for himself, Ms. COLLINS, Mr. LEMIEUX, Mr. TESTER, Mr. 

WHITEHOUSE, Ms. LANDRIEU, Mr. FEINGOLD, Ms. STABENOW, Mr. 

CONRAD, Mrs. MCCASKILL, Mr. CHAMBLISS, Mr. SCHUMER, Mrs. 

GILLIBRAND, Mr. LIEBERMAN, Mr. JOHNSON, Mr. MENENDEZ, Mr. 

GREGG, Mr. LAUTENBERG, Mr. WARNER, Mr. CARPER, Mr. BENNET, 

Mr. CASEY, Ms. CANTWELL, Mr. AKAKA, Mr. CARDIN, Mr. KOHL, Mrs. 

SHAHEEN, Mr. DODD, Mrs. LINCOLN, Mrs. BOXER, Ms. SNOWE, Mr. 

KAUFMAN, Mr. INOUYE, and Mr. BURR) introduced the following bill; 

which was read twice and referred to the Committee on Health, Education, Labor, and Pensions 

DECEMBER 6, 2010 

Reported by Mr. HARKIN, with an amendment and an amendment to the title 

[Strike out all after the enacting clause and insert the part printed in italic] 

A BILL 

To establish the Office of the National Alzheimer’s Project. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

mstockstill on DSKH9S0YB1PROD with BILLS

2 

•S 3036 RS

1 SECTION 1. SHORT TITLE. 

2 This Act may be cited as the ‘‘National Alzheimer’s 

3 Project Act’’. 

4 SEC. 2. OFFICE OF THE NATIONAL ALZHEIMER’S PROJECT. 

5 (a) ESTABLISHMENT OF OFFICE.—There is estab6 lished in the Office of the Secretary of Health and Human 

7 Services the Office of the National Alzheimer’s Project 

8 (referred to in this Act as the ‘‘Office’’). 

9 (b) PURPOSE OF THE OFFICE.—The Office shall— 

10 (1) accelerate the development of treatments 

11 that would prevent, halt, or reverse the course of 

12 Alzheimer’s; 

13 (2) be responsible for the creation and mainte14 nance of an integrated national plan to overcome 

15 Alzheimer’s; 

16 (3) help to coordinate the health care and treat17 ment of citizens with Alzheimer’s; 

18 (4) ensure the inclusion of ethnic and racial 

19 populations at higher risk for Alzheimer’s or least 

20 likely to receive care, in clinical, research, and serv21 ice efforts with the purpose of decreasing health dis22 parities in Alzheimer’s; 

23 (5) coordinate with international bodies to inte24 grate and inform the fight against Alzheimer’s glob25 ally; and 

mstockstill on DSKH9S0YB1PROD with BILLS

3 

•S 3036 RS

1 (6) provide information and coordination of Alz2 heimer’s research and services across all Federal 

3 agencies. 

4 (c) DIRECTOR OF THE OFFICE.— 

5 (1) APPOINTMENT.—The President shall ap6 point a Director of the Office. 

7 (2) DUTIES OF THE DIRECTOR.— 

8 (A) IN GENERAL.—The Director of the Of9 fice shall— 

10 (i) oversee the creation and updating 

11 of the national plan described in subpara12 graph (B); 

13 (ii) use discretionary authority to 

14 evaluate all Federal programs around Alz15 heimer’s, including budget requests and 

16 approvals; and 

17 (iii) prepare and submit to the Presi18 dent the annual budget estimate for the 

19 Office. 

20 (B) NATIONAL PLAN.—The Director of the 

21 Office shall carry out an annual assessment of 

22 the Nation’s progress in preparing for the esca23 lating burden of Alzheimer’s, including both im24 plementation steps and recommendations for 

25 priority actions based on the assessment. 

mstockstill on DSKH9S0YB1PROD with BILLS

4 

•S 3036 RS

1 (3) SERVICE BY DIRECTOR.—The Director of 

2 the Office shall serve on the advisory board of the 

3 Office of Science and Technology to promote re4 search efforts into mechanisms to slow and stop the 

5 development of Alzheimer’s for those at risk of de6 veloping the disease. 

7 (d) ADVISORY COUNCIL.— 

8 (1) IN GENERAL.—There is established in the 

9 Office an Advisory Council on Alzheimer’s Research 

10 and Treatment (referred to in this Act as the ‘‘Advi11 sory Council’’). 

12 (2) MEMBERSHIP.— 

13 (A) FEDERAL MEMBERS.—The Advisory 

14 Council shall be comprised of the following ex15 perts: 

16 (i) A designee of the Centers for Dis17 ease Control and Prevention. 

18 (ii) A designee of the Administration 

19 on Aging. 

20 (iii) A designee of the Centers for 

21 Medicare & Medicaid Services. 

22 (iv) A designee of the Indian Health 

23 Service. 

24 (v) A designee of the Office of the Di25 rector of the National Institutes of Health. 

mstockstill on DSKH9S0YB1PROD with BILLS

5 

•S 3036 RS

1 (vi) The Surgeon General. 

2 (vii) A designee of the National 

3 Science Foundation. 

4 (viii) A designee of the Department of 

5 Veterans Affairs. 

6 (B) NON-FEDERAL MEMBERS.—In addi7 tion to the members outlined in subparagraph 

8 (A), the Advisory Council shall include 12 ex9 pert members from outside the Federal Govern10 ment, which shall include— 

11 (i) 2 Alzheimer patient advocates; 

12 (ii) 2 Alzheimer caregivers; 

13 (iii) 2 health care providers; 

14 (iv) 2 representatives of State health 

15 departments; 

16 (v) 2 researchers with Alzheimer-re17 lated expertise in basic, translational, clin18 ical, or drug development science; and 

19 (vi) 2 voluntary health association 

20 representatives, including a national Alz21 heimer’s disease organization that funds 

22 research and has demonstrated experience 

23 in care and patient services, and a State24 based advocacy organization that provides 

25 services to families and professionals, inmstockstill on DSKH9S0YB1PROD with BILLS

6 

•S 3036 RS

1 cluding information and referral, support 

2 groups, care consultation, education, and 

3 safety services. 

4 (3) MEETINGS.—The Advisory Council shall 

5 meet quarterly and such meetings shall be open to 

6 the public. 

7 (4) ADVICE.—The Advisory Council shall advise 

8 the Director of the Office. 

9 (5) ANNUAL REPORT.—The Advisory Council 

10 shall provide to the Director of the Office— 

11 (A) recommendations for information to be 

12 included in the annual report to Congress by 

13 the Office; and 

14 (B) an annually updated national plan. 

15 (e) ANNUAL REPORT.—The Director of the Office 

16 shall submit to Congress— 

17 (1) an annual report that includes an evalua18 tion of all nationally and federally funded efforts in 

19 Alzheimer’s research, clinical care, institutional, and 

20 home- and community-based programs and their 

21 outcomes; and 

22 (2) an annually updated national plan. 

23 (f) SUNSET.—The Office shall expire on December 

24 31, 2025. 

mstockstill on DSKH9S0YB1PROD with BILLS

7 

•S 3036 RS

1 SECTION 1. SHORT TITLE. 

2 This Act may be cited as the ‘‘National Alzheimer’s 

3 Project Act’’. 

4 SEC. 2. THE NATIONAL ALZHEIMER’S PROJECT. 

5 (a) DEFINITION OF ALZHEIMER’S.—In this Act, the 

6 term ‘‘Alzheimer’s’’ means Alzheimer’s disease and related 

7 dementias. 

8 (b) ESTABLISHMENT.—There is established in the Of9 fice of the Secretary of Health and Human Services the Na10 tional Alzheimer’s Project (referred to in this Act as the 

11 ‘‘Project’’). 

12 (c) PURPOSE OF THE PROJECT.—The Secretary of 

13 Health and Human Services, or the Secretary’s designee, 

14 shall— 

15 (1) be responsible for the creation and mainte16 nance of an integrated national plan to overcome Alz17 heimer’s; 

18 (2) provide information and coordination of Alz19 heimer’s research and services across all Federal agen20 cies; 

21 (3) accelerate the development of treatments that 

22 would prevent, halt, or reverse the course of Alz23 heimer’s; 

24 (4) improve the— 

25 (A) early diagnosis of Alzheimer’s disease; 

26 and 

mstockstill on DSKH9S0YB1PROD with BILLS

8 

•S 3036 RS

1 (B) coordination of the care and treatment 

2 of citizens with Alzheimer’s; 

3 (5) ensure the inclusion of ethnic and racial pop4 ulations at higher risk for Alzheimer’s or least likely 

5 to receive care, in clinical, research, and service ef6 forts with the purpose of decreasing health disparities 

7 in Alzheimer’s; and 

8 (6) coordinate with international bodies to inte9 grate and inform the fight against Alzheimer’s glob10 ally. 

11 (d) DUTIES OF THE SECRETARY.— 

12 (1) IN GENERAL.—The Secretary of Health and 

13 Human Services, or the Secretary’s designee, shall— 

14 (A) oversee the creation and updating of the 

15 national plan described in paragraph (2); and 

16 (B) use discretionary authority to evaluate 

17 all Federal programs around Alzheimer’s, in18 cluding budget requests and approvals. 

19 (2) NATIONAL PLAN.—The Secretary of Health 

20 and Human Services, or the Secretary’s designee, 

21 shall carry out an annual assessment of the Nation’s 

22 progress in preparing for the escalating burden of 

23 Alzheimer’s, including both implementation steps and 

24 recommendations for priority actions based on the as25 sessment. 

mstockstill on DSKH9S0YB1PROD with BILLS

9 

•S 3036 RS

1 (e) ADVISORY COUNCIL.— 

2 (1) IN GENERAL.—There is established an Advi3 sory Council on Alzheimer’s Research, Care, and 

4 Services (referred to in this Act as the ‘‘Advisory 

5 Council’’). 

6 (2) MEMBERSHIP.— 

7 (A) FEDERAL MEMBERS.—The Advisory 

8 Council shall be comprised of the following ex9 perts: 

10 (i) A designee of the Centers for Dis11 ease Control and Prevention. 

12 (ii) A designee of the Administration 

13 on Aging. 

14 (iii) A designee of the Centers for 

15 Medicare & Medicaid Services. 

16 (iv) A designee of the Indian Health 

17 Service. 

18 (v) A designee of the Office of the Di19 rector of the National Institutes of Health. 

20 (vi) The Surgeon General. 

21 (vii) A designee of the National Science 

22 Foundation. 

23 (viii) A designee of the Department of 

24 Veterans Affairs. 

mstockstill on DSKH9S0YB1PROD with BILLS

10 

•S 3036 RS

1 (ix) A designee of the Food and Drug 

2 Administration. 

3 (x) A designee of the Agency for 

4 Healthcare Research and Quality. 

5 (B) NON-FEDERAL MEMBERS.—In addition 

6 to the members outlined in subparagraph (A), 

7 the Advisory Council shall include 12 expert 

8 members from outside the Federal Government, 

9 which shall include— 

10 (i) 2 Alzheimer’s patient advocates; 

11 (ii) 2 Alzheimer’s caregivers; 

12 (iii) 2 health care providers; 

13 (iv) 2 representatives of State health 

14 departments; 

15 (v) 2 researchers with Alzheimer’s-re16 lated expertise in basic, translational, clin17 ical, or drug development science; and 

18 (vi) 2 voluntary health association rep19 resentatives, including a national Alz20 heimer’s disease organization that has dem21 onstrated experience in research, care, and 

22 patient services, and a State-based advocacy 

23 organization that provides services to fami24 lies and professionals, including informamstockstill on DSKH9S0YB1PROD with BILLS

11 

•S 3036 RS

1 tion and referral, support groups, care con2 sultation, education, and safety services. 

3 (3) MEETINGS.—The Advisory Council shall 

4 meet quarterly and such meetings shall be open to the 

5 public. 

6 (4) ADVICE.—The Advisory Council shall advise 

7 the Secretary of Health and Human Services, or the 

8 Secretary’s designee. 

9 (5) ANNUAL REPORT.—The Advisory Council 

10 shall provide to the Secretary of Health and Human 

11 Services, or the Secretary’s designee and Congress— 

12 (A) an initial evaluation of all federally 

13 funded efforts in Alzheimer’s research, clinical 

14 care, and institutional-, home-, and community15 based programs and their outcomes; 

16 (B) initial recommendations for priority 

17 actions to expand, eliminate, coordinate, or con18 dense programs based on the program’s perform19 ance, mission, and purpose; 

20 (C) initial recommendations to— 

21 (i) reduce the financial impact of Alz22 heimer’s on— 

23 (I) Medicare and other federally 

24 funded programs; and 

mstockstill on DSKH9S0YB1PROD with BILLS

12 

•S 3036 RS

1 (II) families living with Alz2 heimer’s disease; and 

3 (ii) improve health outcomes; and 

4 (D) annually thereafter, an evaluation of 

5 the implementation, including outcomes, of the 

6 recommendations, including priorities if nec7 essary, through an updated national plan under 

8 subsection (d)(2). 

9 (6) TERMINATION.—The Advisory Council shall 

10 terminate on December 31, 2025. 

11 (f) DATA SHARING.—Agencies both within the Depart12 ment of Health and Human Services and outside of the De13 partment that have data relating to Alzheimer’s shall share 

14 such data with the Secretary of Health and Human Serv15 ices, or the Secretary’s designee, to enable the Secretary, or 

16 the Secretary’s designee, to complete the report described in 

17 subsection (g). 

18 (g) ANNUAL REPORT.—The Secretary of Health and 

19 Human Services, or the Secretary’s designee, shall submit 

20 to Congress— 

21 (1) an annual report that includes an evaluation 

22 of all federally funded efforts in Alzheimer’s research, 

23 clinical care, and institutional-, home-, and commu24 nity-based programs and their outcomes; 

mstockstill on DSKH9S0YB1PROD with BILLS

13 

•S 3036 RS

1 (2) an evaluation of all federally funded pro2 grams based on program performance, mission, and 

3 purpose related to Alzheimer’s disease; 

4 (3) recommendations for— 

5 (A) priority actions based on the evaluation 

6 conducted by the Secretary and the Advisory 

7 Council to— 

8 (i) reduce the financial impact of Alz9 heimer’s on— 

10 (I) Medicare and other federally 

11 funded programs; and 

12 (II) families living with Alz13 heimer’s disease; and 

14 (ii) improve health outcomes; 

15 (B) implementation steps; and 

16 (C) priority actions to improve the preven17 tion, diagnosis, treatment, care, institutional-, 

18 home-, and community-based programs of Alz19 heimer’s disease for individuals with Alzheimer’s 

20 disease and their caregivers; and 

21 (4) an annually updated national plan. 

22 (h) SUNSET.—The Project shall expire on December 

23 31, 2025. 

mstockstill on DSKH9S0YB1PROD with BILLS

14 

•S 3036 RS

Amend the title so as to read: ‘‘A bill to establish 

the National Alzheimer’s Project.’’. 

mstockstill on DSKH9S0YB1PROD with BILLS

mstockstill on DSKH9S0YB1PROD with BILLS

Calendar No. 675 

111TH CONGRESS 

2D SESSION S. 3036 

A BILL 

To establish the Office of the National Alzheimer’s 

Project. 

DECEMBER 6, 2010 

Reported with an amendment and an amendment to the 

title 

mstockstill on DSKH9S0YB1PROD with BILLS